Description

Ultima-IGF-1 LR3, 0.1 mg

Ultima-IGF-1 LR3 0.1 mg contains IGF-1 LR3 (Insulin-like Growth Factor-1 Long R3), a modified form of IGF-1 developed to provide a longer-lasting activity profile than naturally occurring IGF-1. It is particularly relevant to advanced research involving muscle growth, hypertrophy, recovery, nutrient utilization, and anabolic signaling.

How it works

IGF-1 LR3 interacts with IGF-1 receptors, activating cellular signaling pathways involved in growth, protein synthesis, and tissue development. These pathways include PI3K/Akt/mTOR, which are important in muscle protein synthesis and muscular adaptation.

The LR3 modification changes the molecule’s interaction with IGF-binding proteins and extends its activity compared with native IGF-1, making it particularly interesting for research into muscle development and recovery.

Proper Use and Dosage

The listed product contains 0.1 mg (100 mcg) per vial.

IGF-1 LR3 does not have an established approved human dosing regimen, and experimental protocols vary depending on the research objective.

For a 100 mcg vial:

• 10 mcg = 10 administrations
• 20 mcg = 5 administrations
• 25 mcg = 4 administrations
• 50 mcg = 2 administrations
• 100 mcg = 1 full vial

The 0.1 mg presentation is useful when working with smaller research quantities, allowing more precise measurement without requiring a larger vial.

Benefits

Ultima-IGF-1 LR3 is particularly suited to research involving muscle hypertrophy, recovery, anabolic signaling, and tissue development.

Key benefits and areas of interest include:

• Supports IGF-1 receptor signaling
• Investigated for muscle protein synthesis
• Supports anabolic signaling pathways
• Research interest in muscle hypertrophy
• Supports muscle-recovery research
• Investigated for nutrient utilization
• Supports research into muscle-cell development
• Associated with the PI3K/Akt/mTOR pathway
• Provides an extended-activity IGF-1 analogue
• Convenient 0.1 mg presentation

Its extended activity and connection with IGF-1-mediated growth pathways make IGF-1 LR3 particularly interesting for advanced muscle-development and recovery research.

Side Effects

Possible effects associated with increased IGF-1 activity include headache, dizziness, nausea, fatigue, water retention, and changes in blood glucose. Excessive IGF-1 activity can also contribute to hypoglycemic symptoms, such as sweating, shakiness, weakness, or lightheadedness.

Where to buy 

Whenever bodybuilders want to buy steroids online, it’s always expected that the steroids shop they buy from – Finest Gears, for example – has the products they desire. And luckily, Finest Gears has Ultima-IGF-1 LR3, 0.1 mg in stock.